NYSE LISTED TEST STOCK FOR CTS AND CQS
NYSE LISTED TEST STOCK FOR CTS AND CQS
Market Cap & Net Worth: NYSE LISTED TEST STOCK FOR CTS AND CQS (CBO)
NYSE LISTED TEST STOCK FOR CTS AND CQS (NYSE:CBO) has a market capitalization of $227.43K ($227.43K) as of March 18, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #39049 globally and #12704 in its home market, demonstrating a -1.01% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NYSE LISTED TEST STOCK FOR CTS AND CQS's stock price $25.00 by its total outstanding shares 9097 (9.10K).
NYSE LISTED TEST STOCK FOR CTS AND CQS Market Cap History: 2025 to 2025
NYSE LISTED TEST STOCK FOR CTS AND CQS's market capitalization history from 2025 to 2025. Data shows growth from $227.43K to $227.43K (0.00% CAGR).
NYSE LISTED TEST STOCK FOR CTS AND CQS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NYSE LISTED TEST STOCK FOR CTS AND CQS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of CBO by Market Capitalization
Companies near NYSE LISTED TEST STOCK FOR CTS AND CQS in the global market cap rankings as of March 18, 2026.
Key companies related to NYSE LISTED TEST STOCK FOR CTS AND CQS by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2328 globally with a market cap of $6.43 Billion USD ( €6.27 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2395 globally with a market cap of $6.17 Billion USD ( €6.02 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3760 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4660 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2328 | BERKSHIRE HATH-A | BE:BRH | $6.43 Billion | €634500.00 |
| #2395 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.17 Billion | €638000.00 |
| #3760 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4660 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
NYSE LISTED TEST STOCK FOR CTS AND CQS Historical Marketcap From 2025 to 2025
Between 2025 and today, NYSE LISTED TEST STOCK FOR CTS AND CQS's market cap moved from $227.43K to $ 227.43K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $227.43K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of NYSE LISTED TEST STOCK FOR CTS AND CQS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $227.43K USD |
| MoneyControl | $227.43K USD |
| MarketWatch | $227.43K USD |
| marketcap.company | $227.43K USD |
| Reuters | $227.43K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.